Creative Capital Management Investments »

Vertex Pharmaceuticals Incorporated shares owned by Creative Capital Management Investments

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Creative Capital Management Investments from 13F filings

Historical chart of Creative Capital Management Investments investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Creative Capital Management Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Creative Capital Management Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $10k 24 418.00
2023-12-31 $9.8k 24 406.88
2023-09-30 $8.3k 24 347.75
2023-06-30 $8.4k 24 351.92
2023-03-31 $7.6k 24 315.08
2022-12-31 $7.0k 24 291.67

More positions owned by Creative Capital Management Investments

Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Dimensional World Ex U.s. Core Equity 2 Etf Etf (DFAX)
Dimensional Core Fixed Income Etf Etf (DFCF)
Avantis U.s. Small Cap Value Etf Etf (AVUV)
Dimensional Global Real Estate Etf Etf (DFGR)
Dimensional Emerging Core Equity Market Etf Etf (DFAE)
Powershares Ftse Rafi Us 1000 Etf (PRF)
Apple Stock (AAPL)
Ishares California Muni Bond Etf Etf (CMF)
Amazon.com Stock (AMZN)
Microsoft Stock (MSFT)
Nvidia Corp Stock (NVDA)
Ishares Tips Bond Etf Etf (TIP)
Berkshire Hathaway Inc Del Cl A Stock (BRK.A)
Vanguard Total Stock Market Etf Etf (VTI)

View all positions for Creative Capital Management Investments

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated